Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
1991 1
1993 3
1994 3
1995 5
1996 3
1997 2
1998 2
1999 4
2000 7
2001 3
2002 1
2003 8
2004 4
2005 3
2006 9
2007 5
2008 6
2009 18
2010 21
2011 18
2012 30
2013 25
2014 32
2015 40
2016 57
2017 42
2018 51
2019 96
2020 101
2021 123
2022 161
2023 147
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

944 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
PANoptosis: A New Insight Into Oral Infectious Diseases.
Jiang W, Deng Z, Dai X, Zhao W. Jiang W, et al. Among authors: zhao w. Front Immunol. 2021 Dec 14;12:789610. doi: 10.3389/fimmu.2021.789610. eCollection 2021. Front Immunol. 2021. PMID: 34970269 Free PMC article. Review.
Further understanding of crosstalk between cell death pathways has led to pyroptosis, apoptosis, and necroptosis being integrated into a single term: PANoptosis. PANoptosis is a multifaceted agent of the immune response that has important pathophysiological relevance to in …
Further understanding of crosstalk between cell death pathways has led to pyroptosis, apoptosis, and necroptosis being integrated into a sin …
Red Blood Cell Microparticles Limit Hematoma Growth in Intracerebral Hemorrhage.
Rehni AK, Cho S, Quero HN, Shukla V, Zhang Z, Dong C, Zhao W, Perez-Pinzon MA, Koch S, Jy W, Dave KR. Rehni AK, et al. Among authors: zhao w. Stroke. 2022 Oct;53(10):3182-3191. doi: 10.1161/STROKEAHA.122.039641. Epub 2022 Sep 7. Stroke. 2022. PMID: 36069183 Free PMC article.
The optimal dose, dosing regimen, and therapeutic time window of RMP therapy required to limit hematoma growth post-sICH were determined. We also evaluated the effect of RMPs on long-term behavioral and histopathologic outcomes post-sICH. RESULTS: RMP treatment limited hem …
The optimal dose, dosing regimen, and therapeutic time window of RMP therapy required to limit hematoma growth post-sICH were determined. We …
Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Neonates and Young Infants.
Tang BH, Wu YE, Kou C, Qi YJ, Qi H, Xu HY, Leroux S, Huang X, Zhou Y, Zheng Y, Jacqz-Aigrain E, Shen AD, Zhao W. Tang BH, et al. Among authors: zhao w. Antimicrob Agents Chemother. 2019 Jan 29;63(2):e02336-18. doi: 10.1128/AAC.02336-18. Print 2019 Feb. Antimicrob Agents Chemother. 2019. PMID: 30509939 Free PMC article.
Monte Carlo simulation demonstrated that for early-onset sepsis, the currently used dosage regimen (25 mg/kg twice daily [BID]) resulted in 99.0% of premature neonates and 87.3% of term neonates achieving the pharmacodynamic target (percent time above MIC), using a MIC bre …
Monte Carlo simulation demonstrated that for early-onset sepsis, the currently used dosage regimen (25 mg/kg twice daily [BID]) resulted in …
Efficacy of endoscopic therapy for T1b esophageal cancer and construction of prognosis prediction model: a retrospective cohort study.
Fan X, Wang J, Xia L, Qiu H, Tian Y, Zhangcai Y, Luo X, Gao Y, Li C, Wu Y, Zhao W, Chen J, Shi W, Yuan J, Ke S, Chen Y. Fan X, et al. Among authors: zhao w. Int J Surg. 2023 Jun 1;109(6):1708-1719. doi: 10.1097/JS9.0000000000000427. Int J Surg. 2023. PMID: 37132192 Free PMC article.
BACKGROUND: The efficacy of endoscopic therapy on the long-term survival outcomes of T1b oesophageal cancer (EC) is unclear, this study was designed to clarify the survival outcomes of endoscopic therapy and to construct a model for predicting the prognosis in T1b EC patie …
BACKGROUND: The efficacy of endoscopic therapy on the long-term survival outcomes of T1b oesophageal cancer (EC) is unclear, this stu …
Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression.
Yu H, Tao L, Li YG, Yang L, Liu D, Wang Y, Hao X, He H, Che Y, Wang P, Zhao W, Gao W. Yu H, et al. Among authors: zhao w. Cardiovasc Diabetol. 2023 May 31;22(1):130. doi: 10.1186/s12933-023-01847-y. Cardiovasc Diabetol. 2023. PMID: 37254140 Free PMC article.
However, the prospective relationship between baseline and long-term trajectories of the TyG index and carotid atherosclerosis (CAS) progression has yet to be investigated. ...CONCLUSIONS: Participants with higher baseline and moderate-stable trajectory of the TyG index we …
However, the prospective relationship between baseline and long-term trajectories of the TyG index and carotid atherosclerosis (CAS) …
Short-Term Outcomes Following Laparoscopic vs Open Pancreaticoduodenectomy in Patients With Pancreatic Ductal Adenocarcinoma: A Randomized Clinical Trial.
Wang M, Pan S, Qin T, Xu X, Huang X, Liu J, Chen X, Zhao W, Li J, Liu C, Li D, Liu J, Liu Y, Zhou B, Zhu F, Ji S, Cheng H, Li Z, Li J, Tang Y, Peng X, Yu G, Chen W, Ma H, Xiong Y, Meng L, Lu P, Zhang Z, Yu X, Zhang H, Qin R. Wang M, et al. Among authors: zhao w. JAMA Surg. 2023 Dec 1;158(12):1245-1253. doi: 10.1001/jamasurg.2023.5210. JAMA Surg. 2023. PMID: 37878305
MAIN OUTCOMES AND MEASURES: The primary end point is 5-year overall survival, but the data for this end point are not yet mature; thus, secondary short-term outcomes, including operative findings, complications, mortality, and oncological results are reported here. ...CONC …
MAIN OUTCOMES AND MEASURES: The primary end point is 5-year overall survival, but the data for this end point are not yet mature; thus, seco …
Long-term survival in older patients given propofol or sevoflurane anaesthesia for major cancer surgery: follow-up of a multicentre randomised trial.
Cao SJ, Zhang Y, Zhang YX, Zhao W, Pan LH, Sun XD, Jia Z, Ouyang W, Ye QS, Zhang FX, Guo YQ, Ai YQ, Zhao BJ, Yu JB, Liu ZH, Yin N, Li XY, Ma JH, Li HJ, Wang MR, Sessler DI, Ma D, Wang DX; First Study of Perioperative Organ Protection (SPOP1) investigators. Cao SJ, et al. Among authors: zhao w. Br J Anaesth. 2023 Aug;131(2):266-275. doi: 10.1016/j.bja.2023.01.023. Epub 2023 Jun 4. Br J Anaesth. 2023. PMID: 37474242 Free article. Clinical Trial.
We therefore tested the primary hypothesis that propofol-based anaesthesia improves survival over 3 or more years after potentially curative major cancer surgery. METHODS: This was a long-term follow-up of a multicentre randomised trial in 14 tertiary hospitals in China. . …
We therefore tested the primary hypothesis that propofol-based anaesthesia improves survival over 3 or more years after potentially curative …
Progress in 'taxonomic sufficiency' in aquatic biological investigations.
Chen X, Han M, Liang Y, Zhao W, Wu Y, Sun Y, Shao H, McMinn A, Zhu L, Wang M. Chen X, et al. Among authors: zhao w. Mar Pollut Bull. 2022 Dec;185(Pt A):114192. doi: 10.1016/j.marpolbul.2022.114192. Epub 2022 Nov 7. Mar Pollut Bull. 2022. PMID: 36356341 Review.
The TS approach is stable in the face of different researchers and in the comparison of long-term biological survey data. The effectiveness of the TS approach may increase with increasing environmental gradients or spatial area. ...
The TS approach is stable in the face of different researchers and in the comparison of long-term biological survey data. The effecti …
Tissue-resident memory T cells: The key frontier in local synovitis memory of rheumatoid arthritis.
Gao A, Zhao W, Wu R, Su R, Jin R, Luo J, Gao C, Li X, Wang C. Gao A, et al. Among authors: zhao w. J Autoimmun. 2022 Dec;133:102950. doi: 10.1016/j.jaut.2022.102950. Epub 2022 Nov 7. J Autoimmun. 2022. PMID: 36356551 Review.
Under such circumstances, many patients have to suffer the pain of recurrent attacks as well as the side effects of long-term medication. Current therapies for RA are primarily systemic treatments without targeting the problem that RA is more likely to recur locally. ...
Under such circumstances, many patients have to suffer the pain of recurrent attacks as well as the side effects of long-term medicat …
Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy.
Yan Z, Li L, Fu D, Wu W, Qiao N, Huang Y, Jiang L, Wu D, Hu Y, Zhang H, Xu P, Cheng S, Wang L, Lacin S, Muftuoglu M, Zhao W. Yan Z, et al. Among authors: zhao w. Front Med. 2023 Aug;17(4):699-713. doi: 10.1007/s11684-022-0972-8. Epub 2023 Apr 15. Front Med. 2023. PMID: 37060525
Anti-CD19 chimeric antigen receptor (CAR)-T cell therapy has achieved 40%-50% long-term complete response in relapsed or refractory diffuse large B-cell lymphoma (DLBCL) patients. ...Single-cell RNA sequencing results were obtained from core needle biopsy tumor samples col …
Anti-CD19 chimeric antigen receptor (CAR)-T cell therapy has achieved 40%-50% long-term complete response in relapsed or refractory d …
944 results